Pharmaceuticals UltraSector ProFund
The Pharmaceuticals UltraSector ProFund seeks daily investment results, before fees and expenses, that are 1.5x the return of the Dow Jones U.S. Select Pharmaceuticals Index (the "Index") for a single day.
Fund Snapshot
Fund Snapshot
|
Investor Class |
Service Class |
Ticker |
PHPIX |
PHPSX
|
CUSIP |
743185423 |
743185415
|
Fund Number |
047 |
077
|
Inception Date |
6/28/2000
|
Fund Group |
Sector ProFunds - UltraSector |
Fund Statistics
Fund Statistics
Limits On Exchanges |
None |
Minimum Investment |
Individual Investor |
$15,000 |
Financial Professionals |
$5,000 |
NAV as of 1/27/2021
Class |
NAV |
% Change |
$ Change |
|
Investor |
$28.14 |
-3.83% |
-$1.12 |
NAV History |
Service |
$24.08 |
-3.83% |
-$0.96 |
NAV History |
Chart data provided by Thomson Reuters.
|
Returns (as of 12/31/2020)
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost.
For standardized returns year-to-date, and as of the most recent calendar quarter-end, and annualized month-end, see performance. Returns include the reinvestment of dividends and capital gains.
Returns (as of 12/31/2020)
YTD (as of 1/27/2021) |
1.33% |
Average Annual One Year |
15.48% |
Average Annual Three Year |
5.64% |
Average Annual Five Year |
4.90% |
Average Annual Ten Year |
14.52% |
Average Annual Since Inception |
2.87% |
Cumulative Since Inception |
78.71% |
Gross Expense Ratio |
1.97% |
Net Expense Ratio * |
1.78% |
* Contractual waiver effective from December 1, 2020 through November 30, 2021. Without such a waiver of fees, the total returns may have been lower.
All data, unless otherwise noted, is as of 12/31/2020 and for Investor Class Shares only and is subject to change.
Index/Benchmark
Dow Jones U.S. Select Pharmaceuticals Index*
The Index (Bloomberg Ticker: DJSPHM) measures the performance of the pharmaceuticals sector of the U.S. equity market. Component companies include, among others, manufacturers of prescription or over-the-counter drugs. The Index includes vaccine producers, but excludes vitamin producers. It is not possible to invest directly in an index.
Total Index Companies |
43 |
Price/Earnings Ratio |
52.57 |
Price/Book Ratio |
4.55 |
Dividend Yield |
1.78% |
Average Index Market Capitalization |
31.68 billion
|
Index as of 12/31/2020
Index Sector Weightings |
Weight |
Pharmaceuticals
|
95.10%
|
Biotechnology
|
4.90%
|
Index as of 12/31/2020
As of 12/31/2020
Top 10 Index Companies |
Weight |
Johnson & Johnson
|
22.72%
|
Pfizer Inc.
|
17.19%
|
Catalent Inc.
|
4.98%
|
Viatris Inc.
|
4.73%
|
Eli Lilly & Co.
|
4.72%
|
Elanco Animal Health Inc.
|
4.69%
|
Horizon Therapeutics plc
|
4.61%
|
Zoetis Inc.
|
4.61%
|
Bristol-Myers Squibb Co.
|
4.50%
|
Merck & Co. Inc.
|
4.33%
|
Distributions Sources (PDF)